P10275 |
ANDR_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P10275 |
ANDR_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10275 |
ANDR_HUMAN |
Alcoholic liver disease [ICD-11: DB94] |
P10275 |
ANDR_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P10275 |
ANDR_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P10275 |
ANDR_HUMAN |
Chronic obstructive pulmonary disease [ICD-11: CA22] |
P10275 |
ANDR_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P10275 |
ANDR_HUMAN |
Hypo-osmolality/hyponatraemia [ICD-11: 5C72] |
P10275 |
ANDR_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P10275 |
ANDR_HUMAN |
Mammary tumour [ICD-11: 2C60-2C6Z] |
P10275 |
ANDR_HUMAN |
Pituitary gland disorder [ICD-11: 5A60-5A61] |
P10275 |
ANDR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P10275 |
ANDR_HUMAN |
Testicular dysfunction [ICD-11: 5A81] |
P10275 |
ANDR_HUMAN |
Prostate hyperplasia [ICD-11: GA90] |
P10275 |
ANDR_HUMAN |
Alopecia [ICD-11: ED70] |
P10275 |
ANDR_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
P10275 |
ANDR_HUMAN |
Thrombosis [ICD-11: DB61-GB90] |
P10275 |
ANDR_HUMAN |
Contraceptive management [ICD-11: QA21] |
P10275 |
ANDR_HUMAN |
Heart failure [ICD-11: BD10-BD1Z] |
P10275 |
ANDR_HUMAN |
Muscle disorder [ICD-11: FB32-FB3Z] |
P10275 |
ANDR_HUMAN |
Muscular dystrophy [ICD-11: 8C70] |
P10275 |
ANDR_HUMAN |
Cystic fibrosis [ICD-11: CA25] |
P10275 |
ANDR_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P10275 |
ANDR_HUMAN |
Cachexia [ICD-11: MG20] |
P10275 |
ANDR_HUMAN |
Dissociative neurological symptom disorder [ICD-11: 6B60] |
P10275 |
ANDR_HUMAN |
Bladder cancer [ICD-11: 2C94] |
P10275 |
ANDR_HUMAN |
Oesophagitis [ICD-11: DA24] |
P10275 |
ANDR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10275 |
ANDR_HUMAN |
Prostate hyperplasia [ICD-11: GA90] |
P10275 |
ANDR_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P10275 |
ANDR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P10275 |
ANDR_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P10275 |
ANDR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P04150 |
GCR_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P04150 |
GCR_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P04150 |
GCR_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P04150 |
GCR_HUMAN |
Muscular dystrophy [ICD-11: 8C70] |
P04150 |
GCR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P04150 |
GCR_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P04150 |
GCR_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P04150 |
GCR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P04150 |
GCR_HUMAN |
Adaptive immunity immunodeficiency [ICD-11: 4A01] |
P04150 |
GCR_HUMAN |
Adrenogenital disorder [ICD-11: 5A71] |
P04150 |
GCR_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P04150 |
GCR_HUMAN |
Asthma [ICD-11: CA23] |
P04150 |
GCR_HUMAN |
Atopic eczema [ICD-11: EA80] |
P04150 |
GCR_HUMAN |
Chronic obstructive pulmonary disease [ICD-11: CA22] |
P04150 |
GCR_HUMAN |
Cushing syndrome [ICD-11: 5A70] |
P04150 |
GCR_HUMAN |
Eczema [ICD-11: EA80-EA89] |
P04150 |
GCR_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P04150 |
GCR_HUMAN |
Muscular dystrophy [ICD-11: 8C70] |
P04150 |
GCR_HUMAN |
Oesophagitis [ICD-11: DA24] |
P04150 |
GCR_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P04150 |
GCR_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P04150 |
GCR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P04150 |
GCR_HUMAN |
Spine/trunk injury [ICD-11: ND51] |
P04150 |
GCR_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
P04150 |
GCR_HUMAN |
Herpes simplex infection [ICD-11: 1F00] |
P04150 |
GCR_HUMAN |
Otitis externa [ICD-11: AA00-AA13] |
P04150 |
GCR_HUMAN |
Substance abuse [ICD-11: 6C40] |
P04150 |
GCR_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P04150 |
GCR_HUMAN |
Depression [ICD-11: 6A70-6A7Z] |
P04150 |
GCR_HUMAN |
Mood disorder [ICD-11: 6A60-6E23] |
P04150 |
GCR_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P04150 |
GCR_HUMAN |
Vitamin deficiency [ICD-11: 5B55-5B5F] |
P04150 |
GCR_HUMAN |
Retinopathy [ICD-11: 9B71] |
P04150 |
GCR_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
P04150 |
GCR_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P04150 |
GCR_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P04150 |
GCR_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P04150 |
GCR_HUMAN |
Muscular dystrophy [ICD-11: 8C70] |
P04150 |
GCR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P04150 |
GCR_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P04150 |
GCR_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P04150 |
GCR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P04150 |
GCR_HUMAN |
Adaptive immunity immunodeficiency [ICD-11: 4A01] |
P04150 |
GCR_HUMAN |
Adrenogenital disorder [ICD-11: 5A71] |
P04150 |
GCR_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P04150 |
GCR_HUMAN |
Asthma [ICD-11: CA23] |
P04150 |
GCR_HUMAN |
Atopic eczema [ICD-11: EA80] |
P04150 |
GCR_HUMAN |
Chronic obstructive pulmonary disease [ICD-11: CA22] |
P04150 |
GCR_HUMAN |
Cushing syndrome [ICD-11: 5A70] |
P04150 |
GCR_HUMAN |
Eczema [ICD-11: EA80-EA89] |
P04150 |
GCR_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P04150 |
GCR_HUMAN |
Muscular dystrophy [ICD-11: 8C70] |
P04150 |
GCR_HUMAN |
Oesophagitis [ICD-11: DA24] |
P04150 |
GCR_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P04150 |
GCR_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P04150 |
GCR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P04150 |
GCR_HUMAN |
Spine/trunk injury [ICD-11: ND51] |
P04150 |
GCR_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
P04150 |
GCR_HUMAN |
Herpes simplex infection [ICD-11: 1F00] |
P04150 |
GCR_HUMAN |
Otitis externa [ICD-11: AA00-AA13] |
P04150 |
GCR_HUMAN |
Substance abuse [ICD-11: 6C40] |
P04150 |
GCR_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P04150 |
GCR_HUMAN |
Depression [ICD-11: 6A70-6A7Z] |
P04150 |
GCR_HUMAN |
Mood disorder [ICD-11: 6A60-6E23] |
P04150 |
GCR_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P04150 |
GCR_HUMAN |
Vitamin deficiency [ICD-11: 5B55-5B5F] |
P04150 |
GCR_HUMAN |
Retinopathy [ICD-11: 9B71] |
P04150 |
GCR_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
Q92731 |
ESR2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q92731 |
ESR2_HUMAN |
Cushing syndrome [ICD-11: 5A70] |
Q92731 |
ESR2_HUMAN |
Menopausal disorder [ICD-11: GA30] |
Q92731 |
ESR2_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
Q92731 |
ESR2_HUMAN |
Hepatitis virus infection [ICD-11: 1E50-1E51] |
Q92731 |
ESR2_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q92731 |
ESR2_HUMAN |
Prostate cancer [ICD-11: 2C82] |
Q92731 |
ESR2_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q92731 |
ESR2_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
Q92731 |
ESR2_HUMAN |
Prostate hyperplasia [ICD-11: GA90] |
Q92731 |
ESR2_HUMAN |
Sepsis [ICD-11: 1G40-1G41] |
Q92731 |
ESR2_HUMAN |
Irregularities [ICD-11: N.A.] |
Q92731 |
ESR2_HUMAN |
Trematode disease [ICD-11: 1F8Y] |
Q92731 |
ESR2_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
Q92731 |
ESR2_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
Q92731 |
ESR2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q92731 |
ESR2_HUMAN |
Herpes simplex infection [ICD-11: 1F00] |
Q92731 |
ESR2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P06401 |
PRGR_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P06401 |
PRGR_HUMAN |
Contraceptive management [ICD-11: QA21] |
P06401 |
PRGR_HUMAN |
Menstrual cycle bleeding disorder [ICD-11: GA20] |
P06401 |
PRGR_HUMAN |
Preterm labour/delivery [ICD-11: JB00] |
P06401 |
PRGR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P06401 |
PRGR_HUMAN |
Endometriosis [ICD-11: GA10] |
P06401 |
PRGR_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P06401 |
PRGR_HUMAN |
Endometrial cancer [ICD-11: 2C76] |
P06401 |
PRGR_HUMAN |
Uterine fibroid [ICD-11: 2E86] |
P06401 |
PRGR_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P06401 |
PRGR_HUMAN |
Female genital system disease [ICD-11: GA6Z] |